L
Liqiong Gui
Researcher at Yale University
Publications - 22
Citations - 2246
Liqiong Gui is an academic researcher from Yale University. The author has contributed to research in topics: Tissue engineering & Induced pluripotent stem cell. The author has an hindex of 15, co-authored 22 publications receiving 1978 citations. Previous affiliations of Liqiong Gui include University of Rochester Medical Center & Howard Hughes Medical Institute.
Papers
More filters
Journal ArticleDOI
Tissue-Engineered Lungs for in Vivo Implantation
Thomas Petersen,Elizabeth A. Calle,Liping Zhao,Eun Jung Lee,Liqiong Gui,Micha Sam Brickman Raredon,Kseniya Gavrilov,Tai Yi,Zhen W. Zhuang,Christopher K. Breuer,Erica L. Herzog,Laura E. Niklason +11 more
TL;DR: Treating lungs from adult rats using a procedure that removes cellular components but leaves behind a scaffold of extracellular matrix suggests that repopulation of lung matrix is a viable strategy for lung regeneration.
Journal ArticleDOI
Human iPS cell–derived alveolar epithelium repopulates lung extracellular matrix
Mahboobe Ghaedi,Elizabeth A. Calle,Julio J. Mendez,Ashley L. Gard,Jenna L. Balestrini,Adam J. Booth,Peter F. Bove,Liqiong Gui,Eric S. White,Laura E. Niklason +9 more
TL;DR: A relatively homogeneous population of alveolar epithelial type II and type I cells from human iPSCs that had phenotypic properties similar to those of mature human AETII and AETI cells were generated to explore whether lung tissue can be regenerated in vitro.
Journal ArticleDOI
Development of decellularized human umbilical arteries as small-diameter vascular grafts.
TL;DR: Decellularization of human umbilical arteries preserved the extracellular matrix, supported endothelialization, and retained function in vivo for up to 8 weeks suggest the potential use of decellularized umbilicals arteries as small-diameter vascular grafts.
Journal ArticleDOI
Implantable tissue-engineered blood vessels from human induced pluripotent stem cells.
Liqiong Gui,Biraja C. Dash,Jiesi Luo,Lingfeng Qin,Liping Zhao,Kota Yamamoto,Takuya Hashimoto,Hongwei Wu,Alan Dardik,George Tellides,Laura E. Niklason,Yibing Qyang +11 more
TL;DR: These studies represent the development of the first implantable TEBVs based on hiPSCs, and pave the way for developing autologous or allogeneic grafts for clinical use in patients with vascular disease.
Journal ArticleDOI
Novel Utilization of Serum in Tissue Decellularization
TL;DR: A novel utilization of serum is described that may have broad applications in tissue decellularization, and other types of serum, including human serum, were also shown to remove DNA from detergent-pretreated tissues.